Although the cancer cells displayed increased expression of either β1-integrin (ITGB1) or β4-integrin (ITGB4) upon BEZ235 treatment9 (Supplementary Fig. 1b), only a modest and inconsistent increase in ITGB1 was observed in the mammary glands of DR mice. The gene discussed is ITGB1; the disease is cancer.